Books on the topic 'Percutaneous transluminal coronary angioplasty (PCTA)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 39 books for your research on the topic 'Percutaneous transluminal coronary angioplasty (PCTA).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

1945-, Holmes David R., ed. PTCA, percutaneous transluminal coronary angioplasty. Philadelphia: Davis, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Erlichman, Martin. Patient selection criteria for percutaneous transluminal coronary angioplasty. Rockville, MD: National Center for Health Services Research and Health Care Technology Assessment, U.S. Dept. of Health and Human Services, Public Health Service, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Erlichman, Martin. Patient selection criteria for percutaneous transluminal coronary angioplasty. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Services Research and Health Care Technology Assesment ; Springfield, VA : Available from National Technical Information Service, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Inc, Medical Data International. U.S. markets for percutaneous transluminal coronary angioplasty and coronary stent products. Santa Ana, Calif.]: Medical Data International, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Insight, LLC Medtech. European markets for percutaneous transluminal coronary angioplasty and coronary stenting products. Newport Beach, CA: Medtech Insight, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Guide to coronary angioplasty and stenting. Amsterdam: Harwood Academic Publishers, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rowe, Michael. Angioplasty and other percutaneous interventional techniques in the treatment of ischaemic heart disease: A literature review. [Canberra]: Australian Institute of Health, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vetrovec, George W. Coronary angiography for the interventionalist. New York: Chapman & Hall, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Szlavy, Laszlo. Noncoronary angioplasty and interventional radiologic treatment of vascular malformations. Baltimore: Williams & Wilkins, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Stammen, F. Percutaneous Transluminal Coronary Angioplasty. Leuven University Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Desmet, W. Restenosis After Percutaneous Transluminal Coronary Angioplasty. Leuven University Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Complications of coronary angioplasty. New York: M. Dekker, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

1956-, Hilborne Lee H., New York (State). Cardiac Advisory Committee., and Rand Corporation, eds. Percutaneous transluminal coronary angioplasty: A literature review and ratings of appropriateness and necessity. Santa Monica, CA: Rand, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Reisig, Shirley Eileen. Compliance with risk factor reduction by percutaneous transluminal coronary angioplasty patients. 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Author), New York (Corporate, Rand Corporation (Corporate Author), and Lee H. Hilborne (Editor), eds. Percutaneous Transluminal Coronary Angioplasty: A Review of the Literature Regarding Efficacy and Risks (Rand Corporation//Rand Report). Rand Corp, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Perkins, Sherry Bowman. SELF-EFFICACY AND MOOD STATUS IN RECOVERY FROM PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (CARDIAC REHABILITATION, CORONARY ANGIOPLASTY). 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Restenosis rate after percutaneous transluminal coronary angioplasty in cardiac rehabilitation program participants. 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

1951-, Schwartz Robert S., ed. Coronary restenosis. Boston: Blackwell Scientific Publishers, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

New York (State). Dept. of Health. and New York (State). Cardiac Advisory Committee., eds. Percutaneous coronary interventions (angioplasty) in New York State, 1995-1997. [Albany, N.Y.]: The Department, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

A, Shawl Fayaz, ed. Supported complex and high risk coronary angioplasty. Boston: Kluwer Academic Publishers, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Kopecky, Rebecca L. Midazolam and diazepam for conscious sedation in patients undergoing percutaneous transluminal coronary angioplasty. 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

H, Gohlke, and Ischinger Thomas, eds. Strategies in primary and secondary prevention of coronary artery disease. München ; New York: W. Zuckschwerdt Verlag, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

V, Hombach, Kochs M, and Camm A. John, eds. Interventional techniques in cardiovascular medicine. Dordrecht: Kluwer Academic Publishers, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Porter, Laura Anne. COGNITIVE APPRAISAL OF PSYCHOLOGICAL STRESS, APPRAISAL CONTEXTS AND LIFE DISRUPTION IN PATIENTS HAVING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (ANGIOPLASTY PATIENTS). 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

C, Herrmann Howard, and Hirshfeld John W, eds. Clinical use of the Palmaz-Schatz intracoronary stent. Mount Kisco, NY: Futura Pub. Co., 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

1954-, Naylor C. David, Rand Corporation, Canadian Revascularization Panel, Commonwealth Fund, and Pew Charitable Trusts, eds. Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty: Ratings of appropriateness and necessity by a Canadian Panel. Santa Monica, CA: Rand, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Naylor, C. David. Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty: Ratings of Appropriateness and Necessity by a Canadian Pane. RAND Corporation, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

(Editor), Eulogio Martinez, Pedro A. Lemos (Editor), Andrew T.L. Ong (Editor), and Patrick W. Serruys (Editor), eds. Common Clinical Dilemmas in Percutaneous Coronary Interventions. Informa Healthcare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

E, Martinez Eulógio, ed. Common clinical dilemmas in percutaneous coronary interventions. Abingdon, Oxon: Informa Healthcare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

W, Serruys P., Strauss Bradley H. 1957-, and King Spencer B. 1937-, eds. Restenosis after intervention with new mechanical devices. Dordrecht: Kluwer Academic Publishers, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Pharmacoinvasive therapy in acute myocardial infarction. Boca Raton: Taylor & Francis, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

L, Dauerman Harold, and Sobel Burton E, eds. Pharmacoinvasive therapy in acute myocardial infarction. New York: Marcel Dekker, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Rees, Barbara Boeker. INFLUENCES OF CORONARY ARTERY DISEASE KNOWLEDGE, ANXIETY, SOCIAL SUPPORT, AND SELF-EFFICACY ON ADAPTIVE HEALTH BEHAVIORS OF PATIENTS TREATED WITH A PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY. 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

C, Reeves B., and National Co-ordinating Centre for HTA (Great Britain), eds. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. Tunbridge Wells: Gray Publishing on behalf of NCCHTA, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

G, Callum K., Whimster Fiona, and National Confidential Enquiry into Perioperative Deaths., eds. Percutaneous transluminal coronary angioplasty: A report of the National Confidential Enquiry into Perioperative Deaths : data collection period 1 September 1998 to 31 August 1999. London: National Confidential Enquiry into Perioperative Deaths, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Fye, W. Bruce. Transforming Cardiac Catheters into Treatment Tools. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199982356.003.0016.

Full text
Abstract:
Percutaneous transluminal coronary angioplasty (PTCA) transformed the cardiac catheter from a diagnostic tool into a treatment tool. The technology involved a special catheter fitted with a balloon near its tip that could be blown up to expand a narrowed coronary artery segment. For patients with angina, the procedure was an attractive alternative to coronary bypass surgery. Mayo cardiologists were among the first to adopt angioplasty and to call for controlled clinical trials to compare it to bypass surgery. Initially, cardiologists (who already performed coronary angiography) learned to perform PTCA informally. After attending one or more live demonstration courses, many began to perform angioplasty in their local hospitals. The philosophy in many contexts was “see one, do one.” By the mid-1980s, however, more rigorous training expectations were elaborated. Heart specialists who performed PTCA were described as “interventional cardiologists,” a phrase that acknowledged that this catheter-based treatment had immediate effects.
APA, Harvard, Vancouver, ISO, and other styles
37

T, Rothman Martin, ed. Case studies in interventional cardiology. London: M. Dunitz, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Palmer, Serge Gauthier, Harrison, Appleton, Cohan, Michale Marsh, Juliet Compston, et al. Case Studies in Interventional Cardiology. 6th ed. Informa Healthcare, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Dilsizian, Vasken, Ines Valenta, and Thomas H. Schindler. Myocardial Viability Assessment. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199392094.003.0021.

Full text
Abstract:
Heart failure may be a consequence of ischemic or non-ischemic cardiomyopathy. Etiologies for LV systolic dysfunction in ischemic cardiomyopathy include; 1) transmural scar, 2) nontransmural scar, 3) repetitive myocardial stunning, 4) hibernating myocardium, and 5) remodeled myocardium. The LV remodeling process, which is activated by the renin-angiotensin system (RAS), stimulates toxic catecholamine actions and matrix metalloproteinases, resulting in maladaptive cellular and molecular alterations5, with a final pathway to interstitial fibrosis. These responses to LV dysfunction and interstitial fibrosis lead to progressive worsening of LV function. Established treatment options for ischemic cardiomyopathy include medical therapy, revascularization, and cardiac transplantation. While there has been continuous progress in the medical treatment of heart failure with beta-blockers, angiotensin-converting enzyme (ACE) inhibition, angiotensin II type 1 receptor (AT1R) blockers, and aldosterone to beneficially influence morbidity and mortality, the 5-years mortality rate for heart failure patients remains as high as 50%. Revascularization procedures include percutaneous transluminal coronary artery interventions (PCI) including angioplasty and endovascular stent placement and coronary artery bypass grafting (CABG). Whereas patents with heart failure due to non-coronary etiologies may best benefit from medical therapy or heart transplantation, coronary revascularization has the potential to improve ventricular function, symptoms, and long term survival, in patients with heart failure symptoms due to CAD and ischemic cardiomyopathy.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography